Skip to main content
. 2018 Mar 23;7(5):1944–1954. doi: 10.1002/cam4.1438

Figure 2.

Figure 2

(A) Effects of zaltoprofen on the viability of OUMS27 and SW1353 cells. The cells were treated with or without zaltoprofen for 72 h, followed by WST assay. Asterisks denote a statistically significant difference (*P < 0.05) between cells with and without treatment of zaltoprofen (200 or 400 μmol/L). (B) Representative photos of 5‐ethynyl‐2′‐deoxyuridine (EdU) proliferation assay in PPAR γ knockdown cell lines, OUMS27sh PPAR and SW1353sh PPAR, and the control cell lines, OUMS27sh NTC and SW1353sh NTC with or without the treatment of zaltoprofen for 24 h. Scale bar = 100 μm. (C, D) The EdU‐positive cell ratio [EdU‐positive nuclei (red)/Hoechst 33342‐positive nuclei (blue)] in OUMS27 (C) and SW1353 cells (D). Values represented as the mean ± SEM. Asterisks denote a statistically significant difference (*P < 0.05 and **P < 0.01).